expert roundtables

Advancements in the Risk-Adapted Treatment of Mantle Cell Lymphoma
Oncology

Advancements in the Risk-Adapted Treatment of Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; John M. Pagel, MD, PhD; John P. Leonard, MD
Research Perspectives: Chemotherapy-Free Initial Therapy for Older Patients With Mantle Cell Lymphoma
Oncology

Research Perspectives: Chemotherapy-Free Initial Therapy for Older Patients With Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; John M. Pagel, MD, PhD; John P. Leonard, MD
Optimal Approach to the Management of Difficult-to-Treat Migraine
Neurology

Optimal Approach to the Management of Difficult-to-Treat Migraine

expert roundtables
By David W. Dodick, MD; Deborah I. Friedman, MD, MPH, FAAN, FAHS; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Integrating Newer Migraine Treatments Into Clinical Practice
Neurology

Integrating Newer Migraine Treatments Into Clinical Practice

expert roundtables
By David W. Dodick, MD; Deborah I. Friedman, MD, MPH, FAAN, FAHS; Paul G. Mathew, MD, DNBPAS, FAAN, FAHS
Frontline Treatment Options for Patients With Chronic Lymphocytic Leukemia and Significant Comorbidity
Oncology

Frontline Treatment Options for Patients With Chronic Lymphocytic Leukemia and Significant Comorbidity

expert roundtables
By Matthew S. Davids, MD, MMSc; William G. Wierda, MD, PhD
Load More